-
Featured
The U.S. Chamber of Commerce and other trade and advocacy groups backed Apple Wednesday with amicus briefs telling the Ninth Circuit to reject an appeal from consumers looking to undo the decertification of a class of roughly 200 million people in an antitrust case targeting App Store policies.
-
September 11, 2026
A split Federal Circuit panel Friday upheld Amazon's escape from an infringement case over an AlterWAN Inc. network patent, with the dissenting judge saying the panel needlessly went "down the rabbit hole" and arrived at a "flat wrong" claim construction.
-
September 11, 2026
A medical training startup urged the Federal Circuit on Friday to revive claims accusing Galderma of a "classic catch-and-kill strategy" to derail what it says could have been a $100 million deal with Allergan, but a three-judge panel questioned whether that theory had been properly presented below.
-
September 11, 2026
LCI Industries and Patrick Industries have pulled and refiled their merger notices, giving enforcers with the Federal Trade Commission and U.S. Department of Justice additional time to review a planned merger between two of the nation's biggest RV part suppliers.
-
September 11, 2026
Philip Morris's parent company plans to appeal a North Carolina federal judge's ruling finding a sublicensing agreement between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to pay ongoing royalties under a 2022 jury verdict, according to a notice filed Friday.
-
September 11, 2026
Fanatics and TikTok have been sued by a sports memorabilia seller alleging they orchestrated a "coordinated scheme" intended to push independent livestream "breakers" out of the NFL collectibles market by banning or suppressing them unless they agreed to exclusively buy and sell Fanatics products.
-
September 11, 2026
The Georgia Board of Nursing is urging a federal court to stay litigation alleging that it violated antitrust law by preventing online and out-of-state nursing programs from placing their students at state facilities for clinical rotations, arguing that a proposed rule would likely resolve the suit.
-
September 11, 2026
Google's recent €460 million ($534 million) fine for breaching the European Union's digital markets rules is highly relevant to Kelkoo's U.K. damages claim against the tech giant, the shopping comparison website told the Competition Appeal Tribunal on Friday.
-
September 10, 2026
Thomson Reuters told the Third Circuit Thursday in defunct legal tech startup Ross Intelligence's interlocutory appeal of a summary judgment ruling that it infringed Westlaw headnotes that a statement by the U.S. Department of Justice flagged by Ross does not support its fair-use defense.
-
September 10, 2026
Nektar Therapeutics' damages expert told a California federal jury on Thursday that Eli Lilly & Co. could owe the biotechnology company nearly $1 billion if it finds that the pharmaceutical giant breached a license agreement to co-develop Nektar's autoimmune-disease drug Rezpeg.
-
September 10, 2026
Downstream buyers of cannabis vape brand CCell parts are unable to show that an inherently illegal price-fixing and customer-allocation conspiracy existed between the Chinese manufacturer and four distributors, the companies argued in a dismissal bid, telling a California federal court that the multidistrict litigation complaint describes only "ordinary" business dealings.
-
September 10, 2026
Nielsen is headed back to the Second Circuit after a New York federal court changed the terms of a preliminary injunction that the appellate court had already upheld, the company said, requiring Nielsen to not only unbundle its national radio ratings data from its local offerings but also to provide that data on specific terms.
-
September 10, 2026
Surge ECN Holdings LLC and ECN Operating LLC have accused the former owner of a clinical trial research network of violating a five-year noncompete and other restrictions tied to a deal worth more than $100 million, alleging he diverted customers, recruited key physicians and used confidential information to build a competing business.
-
September 10, 2026
There are no biosimilar drugs in development for 90% of biologic products set to lose their patent exclusivity by 2034, according to a report released Thursday by the Association for Accessible Medicines, which warned that current patent policy threatens generic-drug development.
-
September 10, 2026
Citizens Bank is suing SoFi Bank in Connecticut federal court, alleging its rival poached Citizens Bank employees, stole its trade secrets and "decimated Citizens' mortgage business" in Connecticut.
-
September 10, 2026
The U.S. Department of Justice is asking a New Jersey federal court to overrule an order in the government's monopolization case giving Apple a look at how the Pentagon, CIA, U.S. Department of State and other agencies purchase smartphones and smartwatches.
-
September 10, 2026
Fox News has to produce its top carriage agreements with cable and streaming providers in Newsmax's antitrust suit accusing Fox of pressuring providers not to carry the rival right-leaning broadcaster, a Florida federal magistrate judge ruled Thursday.
-
September 10, 2026
A European Union court refused to upend an EU decision blocking Booking.com's €1.63 billion ($1.89 billion) purchase of Swedish flight booking service eTraveli, rejecting Booking's assertions that the European Commission went against its own merger review guidelines.
-
September 10, 2026
The NCAA's five-year eligibility limit may be a commercial rule subject to antitrust scrutiny, but a Nevada federal judge improperly blocked it to let a college baseball player keep playing with little evidence it constrained competition, the Ninth Circuit has said.
-
September 10, 2026
Private equity firm TPG may be looking to sell Lyric, which could value the healthcare software company at $5 billion; asset manager Blue Owl Capital is exploring the launch of a real estate investment trust; and CVC Capital Partners could sell personal care company Arthea at a $2 billion valuation.
-
September 10, 2026
The U.K.'s antitrust authority said Thursday that it has cleared Welltower Inc.'s $14 billion acquisition of several care homes in the U.K. after the U.S. real estate investment trust took steps earlier in September to address the regulator's concerns.
-
September 10, 2026
The Fifth Circuit found a Texas real estate broker failed to show enough evidence in a third amended complaint to bring antitrust claims challenging rules from the National Association of Realtors that mandate trade group membership to gain access to home listings.
-
September 09, 2026
Nektar Therapeutics failed Wednesday to block evidence of its financial condition from entering into a California federal trial over a failed deal to codevelop its drug Rezpeg with Eli Lilly, after its CEO's testimony on cross-examination prompted the judge to allow the evidence for impeachment purposes.
-
September 09, 2026
Sports technology company Genius Sports Ltd. and Panda Interactive have agreed to settle a patent dispute over technology that allows viewers to see real-time odds and place a bet while watching a sporting event, according to a notice filed in Texas federal court Wednesday.
-
September 09, 2026
A California federal judge denied Deckers Outdoor Corp.'s bid for a new trial over the validity of its design patent for its Ugg Classic Ultra Mini Boot, finding no error in submitting a question of indefiniteness to a jury.
-
September 09, 2026
Hershey, J.M. Smucker and other food makers urged a Minnesota federal judge Tuesday to disqualify Paul Weiss Rifkind Wharton & Garrison LLP from representing Domino Foods in sugar price-fixing multidistrict litigation, arguing the firm is conflicted out because it saw their confidential sugar-purchasing data when it was being considered as plaintiffs' counsel.